A Novel Third-generation EGFR Tyrosine Kinase Inhibitor Abivertinib for EGFR T790M-mutant Non–Small Cell Lung Cancer: a Multicenter Phase I/II Study

Author:

Zhou QingORCID,Wu LinORCID,Hu Pei,An Tongtong,Zhou Jianying,Zhang Li,Liu Xiao-Qing,Luo Feng,Zheng Xin,Cheng Ying,Yang Nong,Li Junling,Feng Jifeng,Han BaohuiORCID,Song Yong,Wang Kai,Zhang Li,Fang Jian,Zhao Hong,Shu Yongqian,Lin Xiao-Yan,Chen Zhihong,Gan Bin,Xu Wan-Hong,Tang Wei,Zhang Xiaoying,Yang Jin-Ji,Xu Xiao,Wu Yi-LongORCID

Funder

Key Lab System Project of Guangdong Science and Technology Department - Guangdong Provincial Key Lab of Translational Medicine in Lung Cancer

High-level Hospital Construction Project

MOST | National Science and Technology Infrastructure Program

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3